DEFA14A ·Filed Apr 23, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine administrative filing. Monitor the company's next 10-Q or 10-K for financial updates and any shareholder vote outcomes from the annual meeting.
Final — all horizons settled through T+60d
INBX ▼ -32.12% at T+60d
NEUTRAL call -32.12% · α vs SPY -37.20% · entry $129.06 → $87.61
T+1d
+1.85%
call +1.85% · α +1.69%
$131.45
settled 6mo ago
T+5d
+0.12%
call +0.12% · α -0.79%
$129.21
settled 6mo ago
T+20d
-14.33%
call -14.33% · α -18.35%
$110.57
settled 5mo ago
T+60d
-32.12%
call -32.12% · α -37.20%
$87.61
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Inhibrx Biosciences filed a definitive proxy statement (DEFA14A) for its 2026 annual meeting. The filing is a routine corporate governance document that provides information about director elections, executive compensation, and shareholder proposals. It does not contain any material financial news or strategic announcements.
Key Financial Metrics
Vote
director election
Meeting
2026-04-23
Key Facts
- Company: Inhibrx Biosciences, Inc. (INBX)
- Filing Type: DEFA14A (Definitive Proxy Statement)
- Filing Date: April 23, 2026
- Purpose: To provide information for the 2026 annual shareholder meeting
Financial Impact
No immediate financial impact
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0002007919-26-000015 |
| Document: 0002007919-26-000015-index-headers.html | 0002007919-26-000015 |
| Document: 0002007919-26-000015-index.html | 0002007919-26-000015 |
| Document: 0002007919-26-000015.txt | 0002007919-26-000015 |
18 reports for INBX
50% Hit rate @ T+60 Went positive at some point 6 of 12 best @ T+60▲ +29.54%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | Insider Buy | $90.50 | awaiting T+60 | — | $97.43 (+7.65%) |
Sep 28, 2026 28d ago | Insider Cluster | $104.83 | awaiting T+60 | — | $97.43 (−7.06%) |
Sep 17, 2026 5w ago | Insider Cluster | $109.35 | awaiting T+60 | — | $97.43 (−10.91%) |
Sep 15, 2026 5w ago | Insider Cluster | $101.77 | awaiting T+60 | — | $97.43 (−4.27%) |
Sep 15, 2026 5w ago | 144 | $101.77 | awaiting T+60 | — | $97.43 (−4.27%) |
Sep 14, 2026 6w ago | 144 | $105.61 | awaiting T+60 | — | $97.43 (−7.75%) |
Sep 11, 2026 6w ago | 144 | $109.27 | awaiting T+60 | — | $97.43 (−10.84%) |
Sep 10, 2026 6w ago | Insider Cluster | $109.27 | awaiting T+60 | — | $97.43 (−10.84%) |
Sep 8, 2026 6w ago | Insider Cluster | $112.86 | awaiting T+60 | — | $97.43 (−13.68%) |
Sep 8, 2026 6w ago | Insider Buy | $112.86 | awaiting T+60 | — | $97.43 (−13.68%) |
Showing 10 of 18
US Market Status
Market Open — Closes in 3h 38m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers